Tomer Kariv
InvestorInvestor at Pontifax Venture Capital
Tel Aviv, Israel
Writes $10M – $50M checks · typically $25M
About
Co-founder and CEO of Pontifax, focused on strategic planning and serving on many portfolio company boards including Keros Therapeutics, Ocon Healthcare, ARMGO, Abcuro, and V-Wave. Previously held senior roles at leading Israeli financial institutions. Holds a B.A. in Economics and a J.D. from Harvard.
Contact· self-published, not guessed
Deals · 1
AbcuroBoard seat
via Pontifax Venture Capital · filed Aug 2023 · $199.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Imel BioTherapeutics
Per SEC Form D filings.
Colleagues at Pontifax Venture Capital
Asaf Shinar
Director at Pontifax Venture Capital
Lina Kaminski
Principal at Pontifax Venture Capital
Momi Karako
General Partner at Viola Credit
Momi Karako
Investment Professional at Pontifax Venture Capital
Ohad Hammer
Investor at Xtripe Angels
Ohad Hammer
Investment Professional at Pontifax Venture Capital
Pat McClain
Principal, Financial Performance at Five Elms Capital
Ran Nussbaum
Managing Partner at Pontifax Venture Capital
Frequently asked questions
- Who is Tomer Kariv?
- Co-founder and CEO of Pontifax, focused on strategic planning and serving on many portfolio company boards including Keros Therapeutics, Ocon Healthcare, ARMGO, Abcuro, and V-Wave. Previously held senior roles at leading Israeli financial institutions. Holds a B.A. in Economics and a J.D. from Harvard.
- Where does Tomer Kariv work?
- Tomer Kariv is Investor at Pontifax Venture Capital.
- What check size does Tomer Kariv write?
- Tomer Kariv typically writes checks of $10M – $50M.
- What boards does Tomer Kariv sit on?
- Tomer Kariv holds tracked board seats at Abcuro, Imel BioTherapeutics.